MannKind Wins FDA Nod for Rapid At-Home Furosemide Shot, Easing Heart Failure Burden
Shares of MannKind Corp. rose sharply last week after regulators cleared its latest version of an injectable diuretic. The approval hands physicians and patients a tool that compresses hours of treatment into seconds. It arrives at a moment when hospital …